| Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study … N Kroger, S Iacobelli, G Franke, U Platzbecker, R Uddin, K Hubel, ... Journal of Clinical Oncology 35 (19), 2157-2164, 2017 | 230 | 2017 |
| Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body … A Nagler, V Rocha, M Labopin, A Unal, T Ben Othman, A Campos, L Volin, ... Journal of clinical oncology 31 (28), 3549-3556, 2013 | 174 | 2013 |
| Maribavir for preemptive treatment of cytomegalovirus reactivation J Maertens, C Cordonnier, P Jaksch, X Poiré, M Uknis, J Wu, A Wijatyk, ... New England Journal of Medicine 381 (12), 1136-1147, 2019 | 139 | 2019 |
| Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial N Jain, E Curran, NM Iyengar, E Diaz-Flores, R Kunnavakkam, ... Clinical cancer research 20 (2), 490-498, 2014 | 131 | 2014 |
| Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow … RF Duarte, A Boumendil, F Onida, I Gabriel, R Arranz, W Arcese, X Poiré, ... Journal of clinical oncology: official journal of the American Society of …, 2014 | 112 | 2014 |
| Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial DJ Winston, KM Mullane, OA Cornely, MJ Boeckh, JW Brown, SA Pergam, ... The Lancet 391 (10135), 2116-2127, 2018 | 98 | 2018 |
| Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT E Jantunen, A Boumendil, H Finel, JJ Luan, P Johnson, A Rambaldi, ... Blood, The Journal of the American Society of Hematology 121 (13), 2529-2532, 2013 | 83 | 2013 |
| Myeloablative and reduced-intensity conditioned allogeneic hematopoietic stem cell transplantation in myelofibrosis: a retrospective study by the Chronic Malignancies Working … D McLornan, R Szydlo, L Koster, Y Chalandon, M Robin, C Wolschke, ... Biology of Blood and Marrow Transplantation 25 (11), 2167-2171, 2019 | 81 | 2019 |
| Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype X Poiré, BK Moser, RE Gallagher, K Laumann, CD Bloomfield, BL Powell, ... Leukemia & lymphoma 55 (7), 1523-1532, 2014 | 71 | 2014 |
| Tandem autologous stem cell transplantation improves outcomes in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the … N Gagelmann, DJ Eikema, L Koster, D Caillot, P Pioltelli, JB Lleonart, ... Biology of blood and marrow transplantation 25 (11), 2134-2142, 2019 | 70 | 2019 |
| Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia RE Gallagher, BK Moser, J Racevskis, X Poiré, CD Bloomfield, AJ Carroll, ... Blood, The Journal of the American Society of Hematology 120 (10), 2098-2108, 2012 | 69 | 2012 |
| Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies: an update of the pivotal clinical trial data G Roex, T Feys, Y Beguin, T Kerre, X Poiré, P Lewalle, P Vandenberghe, ... Pharmaceutics 12 (2), 194, 2020 | 63 | 2020 |
| Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete … S Giebel, M Labopin, M Potter, X Poiré, H Sengeloev, G Socié, A Huynh, ... European journal of cancer 96, 73-81, 2018 | 61 | 2018 |
| Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working … X Poiré, M Labopin, J Maertens, I Yakoub-Agha, D Blaise, N Ifrah, G Socié, ... Journal of hematology & oncology 10, 1-10, 2017 | 58 | 2017 |
| Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A … SP Robinson, A Boumendil, H Finel, D Blaise, X Poire, ... Bone marrow transplantation 51 (3), 365-371, 2016 | 58 | 2016 |
| Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis M Robin, LC De Wreede, C Wolschke, J Schetelig, DJ Eikema, ... haematologica 104 (9), 1782, 2019 | 56 | 2019 |
| Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party PH Prata, DJ Eikema, B Afansyev, P Bosman, F Smiers, JL Diez-Martin, ... Bone marrow transplantation 55 (6), 1050-1058, 2020 | 53 | 2020 |
| Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working … SP Robinson, A Boumendil, H Finel, KS Peggs, P Chevallier, J Sierra, ... Bone marrow transplantation 53 (5), 617-624, 2018 | 49 | 2018 |
| Alemtuzumab in allogeneic hematopoetic stem cell transplantation X Poiré, K van Besien Expert opinion on biological therapy 11 (8), 1099-1111, 2011 | 45 | 2011 |
| Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM … A Xhaard, C Xhaard, M D’aveni, H Salvator, ML Chabi, A Berceanu, ... British journal of haematology 192 (5), e121, 2021 | 43 | 2021 |
